DK3145493T3 - Fremgangsmåder og sammensætninger vedrørende exosomer - Google Patents

Fremgangsmåder og sammensætninger vedrørende exosomer Download PDF

Info

Publication number
DK3145493T3
DK3145493T3 DK15796048.5T DK15796048T DK3145493T3 DK 3145493 T3 DK3145493 T3 DK 3145493T3 DK 15796048 T DK15796048 T DK 15796048T DK 3145493 T3 DK3145493 T3 DK 3145493T3
Authority
DK
Denmark
Prior art keywords
exosomes
methods
compositions relating
relating
compositions
Prior art date
Application number
DK15796048.5T
Other languages
English (en)
Inventor
S Alexander Mitsialis
Stella Kourembanas
Konstantinos Sdrimas
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of DK3145493T3 publication Critical patent/DK3145493T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
DK15796048.5T 2014-05-18 2015-05-15 Fremgangsmåder og sammensætninger vedrørende exosomer DK3145493T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994974P 2014-05-18 2014-05-18
PCT/US2015/031008 WO2015179227A1 (en) 2014-05-18 2015-05-15 Methods and compositions relating to exosomes

Publications (1)

Publication Number Publication Date
DK3145493T3 true DK3145493T3 (da) 2022-10-31

Family

ID=54554566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15796048.5T DK3145493T3 (da) 2014-05-18 2015-05-15 Fremgangsmåder og sammensætninger vedrørende exosomer

Country Status (11)

Country Link
US (2) US10624929B2 (da)
EP (1) EP3145493B1 (da)
JP (2) JP6773563B2 (da)
KR (1) KR20170005854A (da)
CN (2) CN113817672A (da)
AU (1) AU2015264519B2 (da)
CA (1) CA2949083C (da)
DK (1) DK3145493T3 (da)
ES (1) ES2929725T3 (da)
IL (1) IL249011B (da)
WO (1) WO2015179227A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102063069B1 (ko) 2011-03-11 2020-01-08 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
HK1225742A1 (zh) 2013-08-22 2017-09-15 Acceleron Pharma, Inc. TGF-β受体II型变体及其用途
CN120919282A (zh) 2013-11-21 2025-11-11 布里格姆及妇女医院股份有限公司 用于治疗肺高压的组合物和方法
DK3145493T3 (da) 2014-05-18 2022-10-31 Childrens Medical Center Fremgangsmåder og sammensætninger vedrørende exosomer
CN106794233B (zh) 2014-08-01 2021-11-12 布里格姆及妇女医院股份有限公司 与肺动脉高压的治疗有关的组合物和方法
US20160158291A1 (en) * 2014-12-03 2016-06-09 Capricor, Inc. Processes for producing stable exosome formulations
MX2017013852A (es) * 2015-04-28 2019-04-15 Texas A & M Univ Sys Produccion escalable de vesiculas extracelulares estandarizadas, preparaciones de vesiculas extracelular y usos de estos.
US10702581B2 (en) 2015-05-04 2020-07-07 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
WO2017024171A1 (en) 2015-08-04 2017-02-09 Acceleron Pharma Inc. Methods for treating myeloproliferative disorders
CN109152737B (zh) * 2016-03-02 2024-07-12 高等教育联邦系统-匹兹堡大学 结合基质的纳米囊泡及其用途
EP3423070B1 (en) * 2016-03-03 2022-05-04 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
CN105861430B (zh) * 2016-04-29 2019-07-23 南京大学 一种外泌体、外泌体的制备方法及其在制备治疗脓毒症药物或者制剂中的应用
JP2019518049A (ja) * 2016-06-17 2019-06-27 ユナイテッド セラピューティクス コーポレイション 高い効能を有する細胞外小胞
US10946047B2 (en) 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
SG11201900983TA (en) * 2016-08-03 2019-03-28 Univ Nagoya Nat Univ Corp Amelioration and treatment of chronic lung disease using pluripotent stem cells
KR101830290B1 (ko) * 2016-08-05 2018-02-21 한양대학교 에리카산학협력단 지방 유래 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 폐 섬유증 예방 또는 치료용 조성물
WO2018039100A2 (en) * 2016-08-23 2018-03-01 Albert Einstein College Of Medicine, Inc. Stem cell-produced microvesicles for treating tendon pathologies
AU2017335084B2 (en) * 2016-09-30 2023-06-29 Ilias Biologics Inc. Compositions containing protein loaded exosome and methods for preparing and delivering the same
EP3534918A4 (en) * 2016-11-02 2020-07-22 Darwin J. Prockop EXOSOMS AND USES THEREOF IN BRAIN DISEASES
WO2018130554A1 (en) * 2017-01-11 2018-07-19 Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung Mesenchymal stem cell-derived extracellular vesicles and their medical use
KR101973284B1 (ko) * 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
AU2018254498B2 (en) * 2017-04-19 2023-08-03 Figene, Llc Stimulation of angiogenesis by fibroblast derived exosomes
CN107137700B (zh) * 2017-04-27 2021-01-12 张国瑜 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用
LT3628049T (lt) 2017-05-04 2023-08-25 Acceleron Pharma Inc. Tgf-beta ii tipo receptoriaus sulieti baltymai ir jų panaudojimo būdai
KR102872720B1 (ko) 2017-05-05 2025-10-16 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 기질 결합 소낭의 안구에의 적용
JP7037205B2 (ja) 2017-06-30 2022-03-16 エクソコバイオ インコーポレイテッド 幹細胞由来のエキソソームを有効成分として含む組成物のかゆみの抑制又は改善の用途
CN107349220A (zh) * 2017-07-26 2017-11-17 深圳市泰华细胞工程有限公司 一种包含成纤维细胞外泌体的制剂及其用途
AU2018316603B2 (en) 2017-08-15 2024-06-13 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
WO2019083201A2 (ko) * 2017-10-24 2019-05-02 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 신장 기능 개선 용도
GB201718681D0 (en) * 2017-11-13 2017-12-27 Evox Therapeutics Ltd Protein engineered extracellular vesicles
US12036325B2 (en) 2017-12-14 2024-07-16 Mayo Foundation For Medical Education And Research Purified exosome products, method of making, and methods of using
CN108318688B (zh) * 2018-01-10 2019-08-06 浙江大学 外周血外泌体中Smad3蛋白作为分子标记的应用、肝癌检测试剂盒
WO2019168977A1 (en) * 2018-02-27 2019-09-06 Musc Foundation For Research Development Compositions and methods for treating and/or preventing sepsis and/or inflammatory conditions
CA3095134A1 (en) 2018-03-28 2019-10-03 Board Of Regents, The University Of Texas System Identification of epigenetic alterations in dna isolated from exosomes
KR102015502B1 (ko) 2018-03-29 2019-08-28 아키소스템바이오스트래티지스(주) 인간 제대로부터 줄기세포를 분리하는 방법
WO2019198077A1 (en) 2018-04-10 2019-10-17 Brainstorm Cell Therapeutics Ltd. Cell-type specific exosomes and use thereof
AU2019255765B2 (en) * 2018-04-19 2025-02-06 Board Of Regents, The University Of Texas System Therapeutic modulation of tumor suppressors using exosomes
WO2019217091A1 (en) * 2018-04-30 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosomes and uses thereof
EP3787642A4 (en) * 2018-05-03 2022-09-21 University of Pittsburgh - of the Commonwealth System of Higher Education IL-33 CONTAINING MATRIX-BONDED VESICLES (MBVS) AND THEIR USE
CN108865985A (zh) * 2018-06-22 2018-11-23 山东省职业卫生与职业病防治研究院 一种干细胞源外泌体干预上皮-间质转化的方法
CN109266603A (zh) * 2018-08-29 2019-01-25 浙江大学 一种提高心梗疗效的外泌体及应用
CN110876734A (zh) * 2018-09-06 2020-03-13 杨昆德 包含胞外囊泡的制剂、用以制备该制剂的方法及其用途
CN109596841B (zh) * 2019-01-14 2020-04-14 浙江大学 外泌体TβRII蛋白作为标志物在制备乳腺癌检测试剂盒中的应用
KR102300686B1 (ko) 2019-02-15 2021-09-08 이귀선 모터 포인트의 전기 자극으로 발생된 근전도 신호를 감지하여 운동점을 확인할 수 있는 근전도 탐지부를 포함하는 근감소증치료 전기근육자극 장치
CN110115769A (zh) * 2019-04-08 2019-08-13 浙江大学 一种脑靶向外泌体及其制备方法和应用
WO2020231700A1 (en) * 2019-05-11 2020-11-19 Youngsuk Yi Neurotoxin compositions and methods
TW202122569A (zh) * 2019-08-09 2021-06-16 日商宇部興產股份有限公司 應用小片多孔膜的細胞培養法
EP3845566A1 (en) 2019-12-30 2021-07-07 Industrial Technology Research Institute Extracellular vesicle separation method, colloidal particle and preparation method thereof
US12508287B2 (en) 2020-02-13 2025-12-30 Spinalcyte Llc Treatment of cerebral palsy using fibroblasts
AU2021224535A1 (en) * 2020-02-17 2022-09-29 Fibrobiologics, Inc. Telomere length modulation using fibroblasts
EP4142751A4 (en) * 2020-04-01 2025-01-08 Figene, LLC Fibroblast mediated expansion and augmentation of immune regulatory cells for treatment of acute respiratory distress syndrome (ards)
WO2021207192A1 (en) * 2020-04-08 2021-10-14 Figene, Llc Methods and compositions for allergy and asthma treatment using fibroblasts
JP6967308B1 (ja) * 2020-06-30 2021-11-17 国立大学法人高知大学 胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN114377215B (zh) * 2020-10-16 2023-01-31 生物岛实验室 界面修饰的疝气片及其制备方法
US20230112339A1 (en) 2020-10-30 2023-04-13 Vitti Labs Mesenchymal stem cell compositions and methods of making
CN115212234B (zh) * 2021-10-22 2023-11-10 武汉大学中南医院 纤维网状细胞来源的外泌体在制备用于治疗和/或预防脓毒症急性肾损伤的药物中的应用
JPWO2023182507A1 (da) * 2022-03-24 2023-09-28
CN115109741A (zh) * 2022-05-17 2022-09-27 华中农业大学 一种脂质筏的快速分离方法
TWI895950B (zh) * 2023-01-30 2025-09-01 中國醫藥大學 外泌體、其製備方法、其用途以及醫藥組合物

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20040214783A1 (en) 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US8021847B2 (en) * 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US20060286089A1 (en) 2005-04-08 2006-12-21 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
WO2007027157A1 (en) 2005-09-02 2007-03-08 Agency For Science, Technology And Research Method of deriving progenitor cell line
WO2008020815A1 (en) 2006-08-15 2008-02-21 Agency For Science, Technology And Research Mesenchymal stem cell conditioned medium
PL2578081T3 (pl) 2006-10-11 2016-09-30 Kompozycje, sposoby i urządzenia do leczenia chorób wątroby
EP1944361A1 (en) 2007-01-11 2008-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for expanding monocytes
NZ586497A (en) 2008-01-04 2012-07-27 Lydac Neuroscience Ltd Microvesicles
PT2254586E (pt) 2008-02-22 2015-05-18 Agency Science Tech & Res Partículas de células estaminais mesenquimais
US20120107413A1 (en) 2009-07-23 2012-05-03 Singapore Health Services Pte Ltd Pre-natal mesenchymal stem cells
CN102858997B (zh) 2009-11-02 2014-06-18 新加坡科技研究局 用于监测细胞状态和用于永生间充质干细胞的方法
KR101189655B1 (ko) 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
EP2603592A2 (en) * 2010-08-13 2013-06-19 The University Court of the University of Glasgow Therapeutic uses of microvesicles and related micrornas
JP2014507160A (ja) 2011-02-22 2014-03-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． 循環バイオマーカー
KR102063069B1 (ko) * 2011-03-11 2020-01-08 칠드런'즈 메디컬 센터 코포레이션 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물
EP2721179A4 (en) * 2011-06-16 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L BIOMARKER COMPOSITIONS AND METHOD THEREFOR
ITTO20111183A1 (it) 2011-12-21 2013-06-22 Univ Degli Studi Torino Mezzo condizionato ottenuto da cellule staminali mesenchimali placentari e suo uso nel trattamento terapeutico della preeclampsia
US9427450B2 (en) 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
EP3470073A1 (en) * 2012-04-03 2019-04-17 Reneuron Limited Stem cell microparticles
KR101399056B1 (ko) * 2012-04-16 2014-05-27 연세대학교 산학협력단 줄기세포-유래 미세소포체를 유효성분으로 포함하는 신경질환 예방 또는 치료용 약제학적 조성물
AU2013302526B2 (en) * 2012-08-15 2018-03-22 The University Of Chicago Exosome-based therapeutics against neurodegenerative disorders
ES2927175T3 (es) 2013-02-12 2022-11-03 Reneuron Ltd Método de producción de micropartículas
EP2983721B2 (en) 2013-04-12 2021-01-20 Evox Therapeutics Limited Therapeutic delivery vesicles
WO2015018915A1 (de) 2013-08-07 2015-02-12 Pi Ceramic Gmbh Keramische Technologien Und Bauelemente Piezokeramischer werkstoff mit reduziertem bleigehalt
WO2016043654A1 (en) 2014-09-15 2016-03-24 Agency For Science, Technology And Research Methods of treating graft versus host disease (gvhd) or epidermolysis bullosa (eb) with exosomes
US20160220613A1 (en) 2013-09-16 2016-08-04 Agency For Science, Technology And Research Method
DK3145493T3 (da) 2014-05-18 2022-10-31 Childrens Medical Center Fremgangsmåder og sammensætninger vedrørende exosomer
CN105769916B (zh) 2016-04-29 2019-07-23 南京大学 间充质干细胞来源外泌体在制备治疗子痫前期药物或者制剂中的应用
JP2019518049A (ja) 2016-06-17 2019-06-27 ユナイテッド セラピューティクス コーポレイション 高い効能を有する細胞外小胞
KR101973284B1 (ko) 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 ｈｉｅ 치료용 조성물
AU2018243554C1 (en) 2017-03-31 2025-01-30 Wisconsin Alumni Research Foundation Generation of therapeutic cells using extracellular components of target organs
AU2018316603B2 (en) 2017-08-15 2024-06-13 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
WO2019217091A1 (en) 2018-04-30 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosomes and uses thereof
CA3099042A1 (en) 2018-05-09 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosome -treated monocytes and uses thereof
US20210315940A1 (en) 2018-09-05 2021-10-14 Children's Medical Center Corporation Use of mesenchymal stromal cell exosomes in antenatal therapy

Also Published As

Publication number Publication date
CA2949083A1 (en) 2015-11-26
CN106714781A (zh) 2017-05-24
ES2929725T3 (es) 2022-12-01
AU2015264519A1 (en) 2016-12-15
JP2021020908A (ja) 2021-02-18
WO2015179227A1 (en) 2015-11-26
US20200281983A1 (en) 2020-09-10
KR20170005854A (ko) 2017-01-16
AU2015264519B2 (en) 2021-01-28
IL249011A0 (en) 2017-01-31
EP3145493A4 (en) 2018-05-30
CN106714781B (zh) 2021-08-10
US10624929B2 (en) 2020-04-21
EP3145493B1 (en) 2022-07-27
JP6773563B2 (ja) 2020-10-21
JP2017517505A (ja) 2017-06-29
IL249011B (en) 2021-12-01
US20170258840A1 (en) 2017-09-14
EP3145493A1 (en) 2017-03-29
US11759481B2 (en) 2023-09-19
CN113817672A (zh) 2021-12-21
CA2949083C (en) 2023-10-10

Similar Documents

Publication Publication Date Title
IL249011A0 (en) Methods and preparations related to exosomes
KR20180084891A (ko) 구조 조성물 및 방법
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3169733T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3169741T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3221363T3 (da) Antistoffer mod cd73 og anvendelser deraf
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3215173T3 (da) Glycopeptidsammensætninger
DK3040326T3 (da) Haloolefin-baseret sammensætning
LT3102555T (lt) Junginių kompozicijos ir jų panaudojimas
DK3324932T3 (da) Sammensætninger og fremgangsmåder for nanopartikel lyofile former
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
FR3024363B1 (fr) Composition thermogelifiable
PL3154515T3 (pl) Udoskonalenia kompozycji donosowych i sposób ich stosowania
DK3212776T3 (da) Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
IL257458B1 (en) Dpep-1 binding compositions and methods of use
HUE070090T2 (hu) Összetétel
DK3223846T3 (da) Adjuvanssammensætninger og tilhørende fremgangsmåder
DK3166960T3 (da) Lav-substituerede polymyxiner og sammensætninger deraf
DK3200827T3 (da) Sammensætninger
DK3099314T3 (da) Tolerogene sammensætninger og anvendelser deraf
DK3068428T3 (da) Annexin-ii-variant-sammensætninger og fremgangsmåder